Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of cutaneous melanoma.

× No keyword cloud information.

235 in total

1. Dividing and conquering: controlling advanced melanoma by targeting oncogene-defined subsets.

Authors: Keith T Flaherty
Journal: Clin Exp Metastasis Date: 2012-06-03 Impact factor: 5.150

Review 2. Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.

Authors: Scott E Woodman; Michael A Davies
Journal: Biochem Pharmacol Date: 2010-05-08 Impact factor: 5.858

3. Cutaneous melanoma in situ: translational evidence from a large population-based study.

Authors: Simone Mocellin; Donato Nitti
Journal: Oncologist Date: 2011-05-31

Review 4. Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors: Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal: Oncoimmunology Date: 2017-04-05 Impact factor: 8.110

5. Nanoliposomal delivery of cytosolic phospholipase A₂ inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Authors: Raghavendra Gowda; Saketh S Dinavahi; Soumya Iyer; Shubhadeep Banerjee; Rogerio I Neves; Colette R Pameijer; Gavin P Robertson
Journal: Nanomedicine Date: 2018-01-06 Impact factor: 5.307

6. Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.

Authors: Susann-Cathrin Schüle; Thomas Kurt Eigentler; Claus Garbe; Christian la Fougère; Konstantin Nikolaou; Christina Pfannenberg
Journal: Eur J Nucl Med Mol Imaging Date: 2015-09-18 Impact factor: 9.236

7. Psychological changes in melanoma patients during ipilimumab treatment compared to low-dose interferon alpha therapy-a follow-up study of first experiences.

Authors: Péter Kovács; Gitta Pánczél; Kinga Borbola; Gabriella Juhász; Gabriella Liszkay
Journal: Pathol Oncol Res Date: 2014-04-27 Impact factor: 3.201

Review 8. Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors: Murielle Mimeault; Surinder K Batra
Journal: Drug Discov Today Date: 2012-08-10 Impact factor: 7.851

9. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Authors: Luca Szalontay; Andrew V Schally; Petra Popovics; Irving Vidaurre; Awtar Krishan; Marta Zarandi; Ren-Zhi Cai; Anna Klukovits; Norman L Block; Ferenc G Rick
Journal: Cell Cycle Date: 2014 Impact factor: 4.534

10. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.

Authors: Andy J Chien; Erin C Moore; Anke S Lonsdorf; Rima M Kulikauskas; Bonnie Gould Rothberg; Aaron J Berger; Michael B Major; Sam T Hwang; David L Rimm; Randall T Moon
Journal: Proc Natl Acad Sci U S A Date: 2009-01-14 Impact factor: 11.205